TMCnet News
Research and Markets: Sexually Transmitted Diseases Partnering 2007-2013DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/82473v/sexually) has announced the addition of the "Sexually Transmitted Diseases Partnering 2007-2013" report to their offering. The Sexually Transmitted Diseases Partnering 2007-2013 report provides understanding and access to the sexually transmitted diseases partnering deals and agreements entered into by the worlds leading healthcare companies. - Trends in sexually transmitted diseases partnering deals - Top sexually transmitted diseases deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The Sexually Transmitted Diseases Partnering 2007-2013 provides understanding and access to the sexually transmitted diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of sexually transmitted diseases partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors sexually transmitted diseases technology. These deas tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not. This data driven report contains over 20 links to online copies of actual sexually transmitted diseases deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. Benefits Sexually Transmitted Diseases Partnering 2007-2013 provides the reader with the following key benefits: - In-depth understanding of sexually transmitted diseases deal trends since 2007 - Access to summary headline, upfront, milestone and royalty data - Comprehensive access to over 20 actual sexually transmitted diseases deals entered into by the world's biopharma companies since 2007 - Insight into key deal terms included in contracts, where disclosed - Understand the key deal terms companies have agreed in deals - Undertake due diligence to assess suitability of your proposed deal terms for partner companies Key Topics Covered: Executive Summary Chapter 1 - Introduction Chapter 2 - Trends in sexually transmitted diseases partnering Chapter 3 - Leading sexually transmitted diseases deals Chapter 4 - Dealmaking directory Chapter 5 - Partnering resource center Appendices For more information visit http://www.researchandmarkets.com/research/82473v/sexually About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
